Mr. Miguel Martin reports
AURORA CANNABIS AND GROW GROUP PLC RENEW MARKET ACCESS SERVICES AGREEMENT FOR MEDICAL CANNABIS IN THE UNITED KINGDOM
Aurora Germany GmbH, a subsidiary of Aurora Cannabis Inc., and Grow Group PLC, a biopharmaceutical company focused on improving access to cannabis-based medicines in the United Kingdom, have extended their long-standing strategic relationship by signing a two-year market access services agreement for the United Kingdom. Aurora was one of the first companies to enter into a strategic relationship with Grow in August, 2019, and since then both companies have become leaders in the rapidly growing medical cannabis market in the United Kingdom.
"We are delighted to extend our existing strategic relationship with Grow," stated Miguel Martin, chief executive officer of Aurora Cannabis. "We have worked successfully with Grow and their joint venture partner, IPS, since entering the U.K. market. Renewing this agreement will help to broaden access for patients by leveraging Grow's work educating physicians and creating awareness of medical cannabis options. Aurora is committed to providing access to legally produced high-quality pharmaceutical-grade medical cannabis to address the needs of the growing European medical cannabis market, made possible with our EU GMP facility, Aurora Nordic."
"Everything we do is with the patient in mind. Addressing patients' needs and broadening access to medical cannabis in the U.K. is at the heart of Grow's strategy," said Pierre van Weperen, managing director of Grow Group, United Kingdom and Ireland. "Quality of products, broad range of offerings and a strong supply chain is critical to serving the U.K.'s fast-growing patient population. Partnering with companies like Aurora will continue to enable us to offer a portfolio of high-quality flowers and extracts to doctors and the patients who will benefit from them. Every day, these products make a difference for patients and we look forward to advancing market access together with Aurora."
About Aurora Cannabis Inc.
Aurora is a global leader in the cannabis industry serving both the medical and consumer markets. Headquartered in Edmonton, Alta., Canada, Aurora is a pioneer in global cannabis dedicated to helping people improve their lives. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Pedanios, Whistler and Reliva cannabidiol. Providing customers with innovative, high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, performance, wellness and recreational markets wherever they are launched.
© 2021 Canjex Publishing Ltd. All rights reserved.